Banner - NPPA Connect
|Articles|September 1, 2002

TIMs make impact on infants

Winston-Salem, N.C. - Separate studies involving atopic dermatitis drugs tacrolimus (Protopic) and pimecrolimus (Elidel) show the topical immunomodulators (TIMs) are safe and effective for off-label use on children under age 2.


Latest CME